Queensland MedTech Innovators Travel to USA for Accelerator Program

Brisbane has seen massive growth in recent years in its Medical Technology and Life Sciences industries, with innovators emerging from a vibrant startup scene ready to step up to the global stage. As home to both Australia’s leading research university (University of Queensland, AFR tertiary rankings 2023) and Australia’s largest research facility (the Translational Research Institute), Brisbane is uniquely positioned to bring new medical technologies to the world.

Now, the Brisbane Economic Development Agency (BEDA) has chosen eleven innovative startups to travel to San Francisco as part of its MedTech Global Accelerator program in order to fast track their connections with international partners for collaboration, investment, and distribution deals.

These innovators include: 

• Convergence Medical, who are developing a world-first surgical robot for a common procedure that makes up over 50% of orthopaedic operations, treating up to 3.3m patients per year
• Queensland Brain Institute, who have developed an ultrasound technology that effectively removes the plaque that characterises Alzheimer’s Disease
• Vast Bioscience, who are developing non-opioid pain therapies to treat severe and chronic pain and remove the need to use addictive pain relief

…and so many more incredible research and development experts applying their skills to the betterment of humanity.

‍

Brisbane Lord Mayor Adrian Schrinner stated his pride for the city’s contribution to global medicine. 

“Brisbane has a global reputation for developing life-changing health innovation and the continued success of homegrown start-ups around the world will drive economic growth, create new jobs and continue attracting leading talent to the city,” Cr Schrinner said.

“The calibre of businesses participating in the MedTech Accelerator program is testament to the quality of the research and development happening in Brisbane, with more than half of last year’s cohort already securing new partnerships, investment and clients.”

‍

The BEDA program, delivered in partnership with US-based investment facilitator Life Science Nation, will see the cohort connecting with over 300 global investors and strategic partners before culminating with a pitch session to active investors at JP Morgan’s Healthcare Week.